Unplanned admissions to two Sydney public hospitals after naltrexone implants

Lloyd-Jones, D Martyn

doi:10.5694/j.1326-5377.2008.tb02127.x

Topics

To the Editor: In their recent case series, Lintzeris and colleagues state that the symptoms leading to hospital presentation were “associated” with naltrexone implants.1

St Vincent’s Hospital, Melbourne, VIC.

Correspondence: martyn.lloydjones@svhm.org.au

1. Lintzeris N, Lee S, Scopelliti L, et al. Unplanned admissions to two Sydney public hospitals after naltrexone implants. Med J Aust 2008; 188: 441-444. <MJA full text>
2. Ling W, Wesson DR. Naltrexone treatment for addicted health-care professionals: a collaborative private practice experience. J Clin Psychiatry 1984; 45 (9 Pt 2): 46-48.
3. Lloyd-Jones DM. Naltrexone implants: a clinician’s view. Of Substance 2006; 4 (3): 22-23.
4. Comer SD, Sullivan MA, Yu E, et al. Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial. Arch Gen Psychiatry 2006; 63: 210-218.
5. Gibson AE, Degenhardt LJ, Hall WD. Opioid overdose deaths can occur in patients with naltrexone implants. Med J Aust 2007; 186: 152-153. <MJA full text>

Online responses are no longer available. Please refer to our instructions for authors page for more information.